A critical discovery in cancer study is arising with the use of nanobodies to reactivate dysfunctional p53. This essential malignant protector protein is frequently disabled in several types of cancer, leading https://opensocialfactory.com/story27295404/mini-antibodies-restore-p53-the-potential-pathway-for-cancer-management